0 citations
Enalapril in RAPIDISC (wafer formulation): pharmacokinetic evaluation of a novel, convenient formulation
International Journal of Clinical Pharmacology and Therapeutics2000Vol. 38(07), pp. 327–332
Citations Over Time
Lo M-W, Jacqueline B. McCrea, Craig R. Shadle, Michael Hesney, R. Chiou, D Cylc, Andrew Yuan, Michael R. Goldberg
Abstract
This study demonstrates that 20 mg enalapril in RAPIDISC is bioequivalent to 20 mg enalapril conventional tablet.
Related Papers
- → The kinetic profiles of enalapril and enalaprilat and their possible developmental changes in pediatric patients with congestive heart failure(1994)28 cited
- → Pharmacokinetics of Enalapril in Congestive Heart Failure(1986)15 cited
- Enalaprilat: an intravenous substitute for oral enalapril therapy. Humoral and pharmacokinetic effects.(1986)
- → The effect of saturation of ACE binding sites on the pharmacokinetics of enalaprilat in man.(1992)2 cited
- Pharmacokinetics of Enalapril in Rats with Renal Impairment Induced by Adriamycin(2009)